zopolrestat [Ligand Id: 7419] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL10372 (Alond, CP-73,850, CP-73850, Zopolrestat)
There should be some charts here, you may need to enable JavaScript!
  • Aldo-keto reductase family 1 member B10 in Human [ChEMBL: CHEMBL5983] [UniProtKB: O60218]
There should be some charts here, you may need to enable JavaScript!
  • aldo-keto reductase family 1 member B/Aldose reductase in Human [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121]
  • aldo-keto reductase family 1 member B/Aldose reductase in Rat [ChEMBL: CHEMBL2622] [GtoPdb: 2768] [UniProtKB: P07943]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Aldehyde reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2246] [UniProtKB: P14550]
ChEMBL In vitro inhibition of recombinant human aldehyde reductase B 4.41 pIC50 38600 nM IC50 J Med Chem (2005) 48: 3141-3152 [PMID:15857120]
ChEMBL Inhibition of N-terminal 6His-tagged human aldehyde reductase expressed in Escherichia coli BL21(DE3) mediated D-glucuronate reduction B 5.57 pIC50 2700 nM IC50 Bioorg Med Chem (2010) 18: 2485-2490 [PMID:20304656]
Aldo-keto reductase family 1 member B10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5983] [UniProtKB: O60218]
ChEMBL Inhibition of recombinant AKR1B10 assessed as NADP+ dependent reduction of DL-glyceraldehyde by fluorescence assay B 5.63 pIC50 2360 nM IC50 J Med Chem (2012) 55: 2311-2323 [PMID:22263837]
ChEMBL Inhibition of reductase activity of N-terminal 6His-tagged AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as inhibition of NADPH linked pyridine-3-aldehyde reduction B 6.21 pIC50 620 nM IC50 Bioorg Med Chem (2010) 18: 2485-2490 [PMID:20304656]
aldo-keto reductase family 1 member B/Aldose reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121]
ChEMBL Compound was tested for the rate of reduction of glyceraldehyde by human placental aldose reductase. B 7.72 pKi 19 nM Ki J Med Chem (1991) 34: 108-122 [PMID:1899452]
GtoPdb In vitro inhibition of recombinant human aldehyde reductase - 4.41 pIC50 38600 nM IC50 J Med Chem (2005) 48: 3141-52 [PMID:15857120]
ChEMBL Compound was tested for the inhibition of the human placental aldose reductase using the substrate as glyceraldehyde. B 7.09 pIC50 81 nM IC50 J Med Chem (1991) 34: 108-122 [PMID:1899452]
ChEMBL Inhibition of N-terminal 6His-tagged human aldose reductase expressed in Escherichia coli BL21(DE3) mediated NADPH linked pyridine-3-aldehyde reduction B 7.22 pIC50 60 nM IC50 Bioorg Med Chem (2010) 18: 2485-2490 [PMID:20304656]
ChEMBL Inhibition of human recombinant AKR1B1 assessed as D,L-glyceraldehyde reduction pretreated with 1M DMSO followed by compound addition by DMSO-perturbation assay B 7.28 pIC50 52.9 nM IC50 Bioorg Med Chem Lett (2020) 30: 126815-126815 [PMID:31744675]
ChEMBL Inhibition of human recombinant AKR1B1 assessed as D,L-glyceraldehyde reduction pretreated with 0.7M DMSO followed by compound addition by DMSO-perturbation assay B 7.37 pIC50 42.8 nM IC50 Bioorg Med Chem Lett (2020) 30: 126815-126815 [PMID:31744675]
ChEMBL Inhibition of human recombinant AKR1B1 assessed as D,L-glyceraldehyde reduction pretreated with 0.3M DMSO followed by compound addition by DMSO-perturbation assay B 7.42 pIC50 37.8 nM IC50 Bioorg Med Chem Lett (2020) 30: 126815-126815 [PMID:31744675]
ChEMBL Inhibitory Activity against Human recombinant Aldose Reductase (wild type) B 7.44 pIC50 36.4 nM IC50 J Med Chem (2000) 43: 1062-1070 [PMID:10737739]
ChEMBL Inhibition of human recombinant aldose reductase B 7.52 pIC50 30 nM IC50 Bioorg Med Chem (2008) 16: 3245-3254 [PMID:18165015]
ChEMBL Inhibition of recombinant AKR1B1 assessed as NADP+ dependent reduction of DL-glyceraldehyde by fluorescence assay B 7.57 pIC50 27 nM IC50 J Med Chem (2012) 55: 2311-2323 [PMID:22263837]
ChEMBL Inhibition of recombinant human AKR1B1 using D,L-glyceraldehyde as substrate B 7.61 pIC50 24.8 nM IC50 Bioorg Med Chem (2017) 25: 6353-6360 [PMID:29074349]
ChEMBL In vitro inhibition of recombinant human aldose reductase expressed in Escherichia coli B 8.05 pIC50 9 nM IC50 J Med Chem (2005) 48: 3141-3152 [PMID:15857120]
ChEMBL Inhibitory activity against aldose reductase isolated from human placenta B 8.32 pIC50 4.8 nM IC50 J Med Chem (1992) 35: 2155-2162 [PMID:1613743]
ChEMBL In vitro inhibitroy concentration against Aldose reductase incubated at 24 degree C for 15 minutes in pH 7.0 B 8.4 pIC50 4 nM IC50 J Med Chem (2005) 48: 6326-6339 [PMID:16190759]
ChEMBL Inhibition of human recombinant Aldose reductase in streptozotocin diabetic rat B 8.4 pIC50 4 nM IC50 J Med Chem (2003) 46: 2283-2286 [PMID:12773033]
ChEMBL Inhibition of human placental aldose reductase using glyceraldehyde as substrate in presence of NADPH B 8.51 pIC50 3.1 nM IC50 Eur J Med Chem (2017) 138: 1002-1033 [PMID:28759875]
ChEMBL Inhibition of aldose reductase (aldo-keto reductase, AKR1B1) isolated from human placenta. B 8.51 pIC50 3.1 nM IC50 J Med Chem (1991) 34: 108-122 [PMID:1899452]
ChEMBL Inhibitory activity against aldose reductase enzyme B 8.51 pIC50 3.1 nM IC50 J Med Chem (2003) 46: 417-426 [PMID:12540241]
ChEMBL In vitro inhibitory activity against aldose reductase isolated from human placenta B 8.51 pIC50 3.1 nM IC50 J Med Chem (1992) 35: 457-465 [PMID:1738141]
ChEMBL Inhibition of human placenta Aldose reductase B 8.68 pIC50 2.1 nM IC50 Bioorg Med Chem (2019) 27: 3979-3997 [PMID:31401008]
ChEMBL Compound was tested for the inhibition of the human placental aldose reductase using the substrate as glyceraldehyde. B 8.72 pIC50 1.9 nM IC50 J Med Chem (1991) 34: 108-122 [PMID:1899452]
aldo-keto reductase family 1 member B/Aldose reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2622] [GtoPdb: 2768] [UniProtKB: P07943]
ChEMBL Compound was tested for the inhibition of the rat lens aldose reductase using the substrate as glyceraldehyde B 7.39 pIC50 41 nM IC50 J Med Chem (1991) 34: 108-122 [PMID:1899452]
ChEMBL Compound was tested for the inhibition of the rat lens aldose reductase using the substrate as glucose. B 8 pIC50 10 nM IC50 J Med Chem (1991) 34: 108-122 [PMID:1899452]
ChEMBL Inhibition of Wistar rat lens aldose reductase 2 B 8.3 pIC50 5 nM IC50 Bioorg Med Chem (2008) 16: 4908-4920 [PMID:18395454]
ChEMBL Inhibition of Wistar rat lens aldose reductase using D,L-glyceraldehyde as substrate incubated for 1 min measured for 4 mins by spectrophotometry B 8.3 pIC50 5 nM IC50 J Med Chem (2015) 58: 2649-2657 [PMID:25695864]
Aldose reductase-related protein 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3421523] [UniProtKB: Q5RJP0]
ChEMBL Inhibition of Wistar rat kidney aldehyde reductase using D-glucuronate as substrate by spectrophotometry B 7.31 pIC50 49 nM IC50 J Med Chem (2015) 58: 2649-2657 [PMID:25695864]
Glyoxalase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2424] [UniProtKB: Q04760]
ChEMBL Inhibition of human Glyoxalase-1 using GSH and MGO as substrate by Dixon plot analysis B 8.92 pKi 1.2 nM Ki Bioorg Med Chem (2020) 28: 115243-115243 [PMID:31879183]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]